Ledger.Open graph →
SEC Form D · filed June 29, 2023

Calidi Biotherapeutics, Inc

Offering
$25.0M
Sold
$5.0M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (32)

Allan Camaisa · San Diego, CAExec · DirectorWendy Pizarro · San Diego, CAExecGeorge R. Ng · San Diego, CADirectorScott R. Leftwich · San Diego, CADirectorBoris Minev · San Diego, CAExecJames A. Schoeneck · San Diego, CADirectorAlfonso F. Zulueta · San Diego, CADirectorTony W. Goodman · Glen Allen, VADirectorDonald H. Kagin · Tiburon, CAExecVinay J. Shah · Glen Allen, VAExec · DirectorJames K. Anderson · Glen Allen, VADirectorJames W. Newman, Jr · Glen Allen, VADirectorCary J. Claiborne · Glen Allen, VAExecHeehyoung F. Lee · San Diego, CADirectorAnthony F. Santidrian · San Diego, CAExecStephen Thesing · San Diego, CAExecTony Kalajian · San Diego, CAExecAmish F. Patel · San Diego, CAExecDavid F. Sans · San Diego, CAExecErica H. Radcliffe · Houston, TXExec · DirectorJohn A. Hill · Stamford, CTDirectorEdward T. Bialas · Stamford, CTExecNeil A. Wizel · Stamford, CTExecAlex T. Krueger · Stamford, CTDirectorGary D. Reaves, Ii · Stamford, CTDirectorHeehyoung F. Lee · San Diego, CADirectorAlfonso F. Zulueta · San Diego, CADirectorAnthony F. Santidrian · San Diego, CAExecStephen Thesing · San Diego, CAExecTony Kalajian · San Diego, CAExecAmish F. Patel · San Diego, CAExecDavid F. Sans · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗